| Bioactivity | IYPTNGYTR acetate, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. IYPTNGYTR acetate can be used to monitor in vivo Trastuzumab metabolism[1]. | ||||||
| Invitro | IYPTNGYTR is deamidated at pH 7.5 and above, with a higher deamidation rate when the pH increases[1]. | ||||||
| Name | IYPTNGYTR acetate | ||||||
| Shortening | IYPTNGYTR | ||||||
| Formula | C51H77N13O17 | ||||||
| Molar Mass | 1144.23 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
IYPTNGYTR acetate
CAS: F: C51H77N13O17 W: 1144.23
IYPTNGYTR acetate, a deamidation-sensitive signature peptide, is a deamidation product of Trastuzumab. IYPTNGYTR acetate
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.